ZEPP
Zepp Health Corp.
NYSE · Technology · Consumer Electronics · CN
$2.92
−3.31%Year over year
Reported trailing growth
- Revenue
- +34.0%
- EBITDA
- +33.5%
- EBIT
- +27.4%
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +43.4%
- EBITDA
- +44.6%
- EBIT
- +40.6%
- Net income
- +49.3%
- EPS
- —
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026